Clinical Trial Update: Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" [Phase 2, Phase 3]

View source ↗

Summary

A completed clinical trial update (STOP MRSA) evaluating off-patent antibiotics for methicillin-resistant Staphylococcus aureus infections, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Staphylococcus Aureus Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Staphylococcal Infection | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-05-28